Chronic hepatitis ameliorates anaemia in haemodialysis patients

Nephrology

Volumn 13, Issue 4, 2008, Pages 289-293

  Lin, Yi Lung ^a   Lin, Chi Wei ^a   Lee, Chieh Hua ^a   Lai, I Chun ^a   Chen, His Hsien ^a   Chen, Tzen Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anaemia; Chronic hepatitis; Dialysis; Erythropoietin

Indexed keywords

ALANINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTIC ACID; CHOLESTEROL; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CHRONIC HEPATITIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TAIWAN; TREATMENT DURATION;

AGED; ALANINE TRANSAMINASE; ANEMIA; ASPARTATE AMINOTRANSFERASES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATINICS; HEMATOCRIT; HEMOGLOBINS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 43949133395     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.00937.x     Document Type: Article

References (36)

1. Natov SN, Pereira BJG. Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients. Semin. Dial. 2000 13 : 393 8.
2. Schneeberger PM, Vos J, van Dijk WC. Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors. J. Hosp. Infect. 1993 25 : 265 70.
3. Barril G, Traver JA. Spanish multicentre study group: Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol. Dial. Transplant. 1995 10 : 78 80.
4. Hayashi J, Nakashima K, Yoshimura E, Kishihara Y, Ohmiya M, Hirata M. Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan. J. Infect. 1994 28 : 271 7.
5. Wreghitt TG. Blood-bore virus infections in dialysis units - A review. Rev. Med. Virol. 1999 9 : 101 9.
6. Lopes EPA, Gouveia EC, Albuquerque ACC et al. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. J. Clin. Virol. 2006 35 : 298 302.
7. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Semin Dial. 1994 : 3601 8.
8. Guh JY, Lai YH, Yang CY et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995 69 : 459 65.
9. Fabrizi F, Lunghi G, Finazzi S et al. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am. J. Kidney Dis. 2001 38 : 1009 15.
10. Sahin I, Arabaci F, Sahin HA. Does hepatitis C virus infection increase hematocrit and hemoglobin levels in hemodialyzed patients? Clin. Nephrol., 2003 60 : 401 4.
11. Meyrier A, Simon P, Boffa G. Uremia and the liver. I. The liver and erythropoiesis in chronic renal failure. Nephron 1981 29 : 3 6.
12. Kolk-Vegter AJ, Bosch E, Van Leeuven AM. Influence of serum hepatitis on haemoglobin levels in patients on regular haemodialysis. Lancet 1971 1 : 526 8.
13. Busek SU, Babá ÉH, Tavares Filho HA et al. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem. Inst. Oswaldo. Cruz. 2002 97 : 775 8.
14. Klassen DK, Spivak JL. Hepatitis-related erythropoietin production. Am. J. Med. 1990 89 : 684 6.
15. Chan N, Barton CH, Mirahmadi MS. Erythropoiesis associated with viral hepatitis in end-stage renal disease. Am. J. Med. Sci. 1984 287 : 56 8.
16. Simon P, Meyrier A, Tanquerel T. Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis. BMJ 1980 280 : 892 4.
17. Rampino T, Arbustini E, Gregorini M et al. Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor. Kidney Int. 1999 56 : 2286 91.
18. Kalantar-Zadeh K, Miller LG, Daar ES et al. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am. J. Kidney Dis. 2005 46 : 290 300.
19. Yuki N, Ishida H, Inoue T et al. Reappraisal of biochemical hepatitis C activity in hemodialysis patients. J. Clin. Gastroenterol. 2000 30 : 187 94.
20. Saab S, Martin P, Brezina M et al. Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am. J. Kidney Dis. 2001 37 : 308 15.
21. Saab S. Hepatitis C virus transmission in the hemodialysis community. Am. J. Kidney Dis. 2001 37 : 1052 5.
22. Saab S, Brezina M, Gitnick G et al. Hepatitis C screening strategies in hemodialysis patients. Am. J. Kidney Dis. 2001 38 : 91 7.
23. Navarro JF, Teruel JL, Villafruela JJ. Hepatitis-associated improvement of anemia in an anephric patient without elevation of serum erythropoietin level. Nephron 1993 65 : 495 8.
24. Pololi-Anagnostou L, Westenfelder C, Anagnostou A. Marked improvement of erythropoiesis in an anephric patient. Nephron 1981 29 : 277 9.
25. Brown S, Caro J, Erslev AJ. Spontaneous increase in erythropoietin and hematocrit values associated with transient liver enzyme abnormalities in an anephric patient undergoing hemodialysis. Am. J. Med. 1980 68 : 280 84.
26. Radovic M, Jelkmann W, Djukanovic L. Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. J. Interferon Cytokine Res. 1999 19 : 369 73.
27. Goicoechea M, Martin J, de Sequera P. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int. 1998 54 : 1337 43.
28. Naughton BA, Kaplan SM, Roy M. Hepatitis regeneration and erythropoietin production in the rat. Science 1977 196 : 301 2.
29. Yuen D, Richardson RM, Fenton SS. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J. 2005 51 : 236 41.
30. Jelkmann WE, Fandrey J, Frede S. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann. N. Y. Acad. Sci. 1994 718 : 300 309.
31. Tacke F, Schoffski P, Luedde T. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand. J. Gastroenterol. 2004 39 : 259 66.
32. Fabris C, Soardo G, Falleti E. Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-α in chronic hepatitis C. J. Interferon Cytokine Res. 1998 18 : 705 9.
33. Gregory SH, Wing EJ, Danowski KL. IL-6 produced by kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J. Immunol. 1998 160 : 6056 61.
34. Feder LS, Todaro JA, Laskin DL. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J. Leukoc. Biol. 1993 53 : 126 32.
35. Heinrich PC, Behrmann I, Muller-Newen G. Interleukin-6-t ype cytokine signalling through the gp130/Jak/Stat pathway. Biochem. J. 1998 334 : 297 314.
36. Mackiewicz A, Schooltink H, Heinrich PC. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 1992 6 : 2021 7.